Media coverage about Steris Plc (NYSE:STE) has been trending somewhat negative this week, Accern Sentiment Analysis reports. The research group scores the sentiment of news coverage by reviewing more than 20 million blog and news sources in real time. Accern ranks coverage of companies on a scale of negative one to one, with scores closest to one being the most favorable. Steris Plc earned a coverage optimism score of -0.01 on Accern’s scale. Accern also gave news articles about the company an impact score of 46.3853955678244 out of 100, meaning that recent news coverage is somewhat unlikely to have an impact on the company’s share price in the immediate future.
Here are some of the news articles that may have effected Accern’s rankings:
- North America to Offer High Growth Opportunities to Players in Operating Room Management Market During the 2017 – 2022 Timeline (sbwire.com)
- Analysts Anticipate Steris Plc (STE) to Announce $1.07 EPS (americanbankingnews.com)
- Steris Plc (STE) Receives Average Rating of “Hold” from Brokerages (americanbankingnews.com)
- Stellar Metrics for Earnings Growth Keep Steris (STE) a Strong Buy (investorplace.com)
- STERIS Plc – Value Analysis (NYSE:STE) : November 6, 2017 (finance.yahoo.com)
Steris Plc (STE) opened at C$86.85 on Friday. Steris Plc has a twelve month low of C$64.37 and a twelve month high of C$93.39. The company has a debt-to-equity ratio of 0.48, a current ratio of 2.80 and a quick ratio of 2.18. The company has a market capitalization of $7,386.77, a price-to-earnings ratio of 22.38 and a beta of 1.31.
Steris Plc (NYSE:STE) last posted its quarterly earnings results on Wednesday, November 1st. The company reported C$0.94 EPS for the quarter, missing the Zacks’ consensus estimate of C$0.95 by C($0.01). Steris Plc had a return on equity of 11.49% and a net margin of 5.59%. The company had revenue of C$634.20 million during the quarter, compared to the consensus estimate of C$629.02 million. During the same period in the previous year, the business earned $0.89 earnings per share. Steris Plc’s revenue was down 1.9% on a year-over-year basis. research analysts anticipate that Steris Plc will post 4.06 EPS for the current fiscal year.
The business also recently declared a quarterly dividend, which will be paid on Wednesday, December 20th. Stockholders of record on Wednesday, November 22nd will be issued a $0.31 dividend. This represents a $1.24 dividend on an annualized basis and a dividend yield of 1.43%. The ex-dividend date of this dividend is Tuesday, November 21st. Steris Plc’s payout ratio is currently 73.81%.
A number of analysts have issued reports on STE shares. Raymond James Financial, Inc. raised their target price on Steris Plc from $95.00 to $100.00 and gave the stock an “outperform” rating in a research report on Monday, October 16th. KeyCorp reissued a “buy” rating and issued a $91.00 target price on shares of Steris Plc in a research report on Tuesday, October 17th. Zacks Investment Research downgraded Steris Plc from a “buy” rating to a “hold” rating in a research report on Tuesday, August 22nd. BidaskClub downgraded Steris Plc from a “strong-buy” rating to a “buy” rating in a research report on Monday, July 31st. Finally, TD Securities raised their target price on Steris Plc from C$14.00 to C$16.00 and gave the stock a “buy” rating in a research report on Thursday. One equities research analyst has rated the stock with a sell rating, two have given a hold rating and four have given a buy rating to the company. Steris Plc currently has a consensus rating of “Hold” and a consensus target price of C$77.80.
COPYRIGHT VIOLATION NOTICE: “Somewhat Negative Press Coverage Somewhat Unlikely to Impact Steris Plc (STE) Share Price” was first reported by Markets Daily and is the sole property of of Markets Daily. If you are reading this story on another publication, it was copied illegally and reposted in violation of U.S. and international trademark and copyright law. The original version of this story can be read at https://www.themarketsdaily.com/2017/11/12/somewhat-negative-press-coverage-somewhat-unlikely-to-impact-steris-plc-ste-share-price.html.
In related news, insider Michael J. Tokich sold 12,000 shares of Steris Plc stock in a transaction on Wednesday, October 4th. The stock was sold at an average price of C$89.75, for a total transaction of C$1,077,000.00. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is available at this link. Also, insider Michael J. Tokich sold 11,000 shares of Steris Plc stock in a transaction on Monday, October 23rd. The shares were sold at an average price of C$92.00, for a total value of C$1,012,000.00. Following the sale, the insider now directly owns 58,588 shares of the company’s stock, valued at approximately C$5,390,096. The disclosure for this sale can be found here. Insiders sold 202,342 shares of company stock valued at $17,729,692 over the last ninety days. Corporate insiders own 2.55% of the company’s stock.
Steris Plc Company Profile
STERIS plc provides infection prevention and other procedural products and services. The Company operates through four segments: Healthcare Products, which offers infection prevention and procedural solutions for healthcare providers, including capital equipment and related maintenance, and installation services, as well as consumables; Healthcare Specialty Services, which provides a range of specialty services for healthcare providers, including hospital sterilization services, instrument and scope repairs, and linen management; Life Sciences, which offers capital equipment and consumable products, and equipment maintenance and specialty services for pharmaceutical manufacturers and research facilities, and Applied Sterilization Technologies, which offers contract sterilization and laboratory services for medical device and pharmaceutical customers and others.
Receive News & Ratings for Steris Plc Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Steris Plc and related companies with MarketBeat.com's FREE daily email newsletter.